Psychedelics, Depression be gone

Psychedelics, Depression be gone
Erfan Rasti,^1,*
1. Tbilisi State Medical University
Introduction: In recent years there has been an uprising in various methods of treatment for clinical depression and anxiety, in particular the use of ancient and perhaps shunned substances such as psychedelics including Psilocybin, LSD and DMT have come into play and many studies and clinical trials have proved them beneficiary for patients, especially those who were deemed otherwise helpless and were unresponsive to mainstream treatments. This is an overall review of the clinical trials and research studies done so far and a plea for some open mindedness and nuance from colleagues and officials.
Methods: All the various types of clinical trials and research methods have been utilized in the studies and trials that I have cited in my article.
Results: Almost all results have conclusively been that utilizing psychedelics for the treatment of clinical depression and anxiety in patients have had either extraordinary benefits or benefited the patients enough to warrants serious consideration of making the treatment mainstream and accessible to all.
Conclusion: There must be new regulations and funds set in place for further proving the results and making the treatments available to patients all around the world.
Keywords: Treatments, Research, Psychedelics, Medical professionals.